Breast Cancer Misdiagnoses in Bremen: What Patients Need to Know
Table of Contents
As of December 4th, 2025, a concerning number of women in Bremen, Germany – 34 in total – have received incorrect breast cancer diagnoses, leading to inappropriate treatment and ongoing suffering. Experts are now advising patients on how to navigate potential diagnostic errors and advocate for their care.
Some women underwent chemotherapy unnecessarily, while others were denied crucial treatment they desperately needed. Many continue to grapple with the consequences of these errors, highlighting a critical breakdown in the diagnostic process.
“How can I, as a layperson, determine whether the treatment suits my findings?” This is a question on the minds of many patients, and one addressed by Susanne Weg-Remers, head of the cancer information service at the German Cancer Research Center. Weg-Remers emphasizes the importance of proactive patient engagement.
“As a patient, can I even tell whether the recommended therapy fits my cancer diagnosis and the pathological findings?” she asks, acknowledging the complexity of the situation. The answer, she explains, is not straightforward.
Patients can, and should, consult with a doctor in private practice – such as their gynecologist – to review their findings and proposed treatment plan. “You can ask him to take a look at it,” Weg-Remers advises.
But what if that second doctor expresses doubt? “If he says: ‘I have doubts’, there is of course the option of first speaking to the treating doctors again and asking them to explain again what the findings are and also explain how the treatment fits the findings,” she explains. Open communication with the original medical team is paramount.
However, if communication fails to resolve concerns, seeking a second medical opinion is crucial. “Our advice is always to have a conversation and try to communicate with the treating doctors – if that doesn’t work, there is of course the option of getting a second medical opinion.” This involves having another doctor independently review the patient’s pathology results.
The Bremen Case: A Unique Challenge
The situation in Bremen presents a particularly difficult scenario. Weg-Remers points out that the core issue isn’t a disagreement about treatment given correct findings, but rather that the initial pathological findings themselves are wrong. “But I think especially now in the Bremen case the situation is a little different because the pathological findings, which are the basis of the therapy recommendation, are wrong. And if they are already wrong, then it actually becomes difficult.”
This creates a significant hurdle. “If the treatment matches this pathological finding, but the finding is not correct, you actually have a big problem recognizing it and the doctor cannot necessarily recognize it in the second opinion.” A second opinion, while still valuable, may be misled by flawed initial data.
How Rare Are Pathological Errors?
Incorrect pathological findings are, thankfully, “very unusual.” Weg-Remers stresses that all pathology departments employ rigorous quality management systems to ensure accuracy. “This is very unusual, so all pathologies have quality management that really ensures that the findings that come out are correct. Because they represent the basis for all therapeutic decisions. You have to be able to rely on them.”
The Bremen case understandably erodes patient trust. When asked if patients should routinely seek second opinions to protect themselves, Weg-Remers suggests a targeted approach. “Ultimately, if the case is like that in Bremen, you would need a second opinion on the pathology findings. This means that the tissue preparations that were prepared and examined in pathology would have to be sent to another pathology department in order to check the findings.”
The interview for Bremen Zwei was conducted by Hendrik Plaß, with editing and transcription by Lina Brunnée.
